Table 4.
DFS | OS | |||||
---|---|---|---|---|---|---|
HR | 95% CI | p-Value | HR | 95% CI | p-Value | |
Grade 1 vs. 2 vs. 3 | - | - | 0.560 | - | - | 0.977 |
Ki-67 ≥ 20% vs. <20% | 0.8 | 1.8–35.5 | 0.006 | 0.260 | ||
ER ≥ 10% vs. <10% | - | - | 0.072 | 3.2 | 1.3–7.7 | 0.008 |
pCR vs. no pCR | 0.2 | 0.0–0.6 | 0.009 | - | - | 0.06 |
HIF-1α ≥ 5% vs. <5% | 2.5 | 1.0–6.2 | 0.047 | - | - | 0.295 |
pAKT ≥ 10% vs. <10% | 2.4 | 1.0–5.9 | 0.039 | 2.4 | 1.0–5.7 | 0.046 |
Abbreviations: DFS, disease-free survival; ER, estrogen receptor; HR, Hazard ratio; OS, overall survival; Italic means the p-value is significant.